US · Healthcare

Alterity Therapeutics Limited (PRNAF)

Biotechnology

Alterity Therapeutics Limited (PRNAF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PRNAF

P/E ratio

25.00

Alterity Therapeutics Limited (PRNAF) — FAQ

What is PRNAF's P/E ratio?

The price-to-earnings (P/E) ratio for Alterity Therapeutics Limited (PRNAF) is 25.00 (data as of 2026-05-23).

Does Alterity Therapeutics Limited pay a dividend?

Dividend yield is not available in the current snapshot for Alterity Therapeutics Limited (PRNAF). Check the MyAverix Finance app for the latest dividend data.

What sector is Alterity Therapeutics Limited in?

Alterity Therapeutics Limited (PRNAF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PRNAF listed on?

PRNAF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)